For past Congresses, use the Browse menu.
HR 6400
118th Congress • 2023–2025 (Ended)

To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.


Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…